Myomo Q2 FY26 operating loss narrows 51% to $2.3 million; revenue rises 21% to $11.7 million

• Myomo posted Q2 2026 revenue of $11.7 million, up 21% year over year; net loss narrowed to $4 million, or $0.09 a share.
• Gross margin expanded 9.4 percentage points to 72.1%.
• Operating loss narrowed to $2.3 million as operating expenses held at $10.7 million, up less than 1%.
• Adjusted EBITDA loss narrowed to $827,282 from $4 million a year earlier; cash, cash equivalents and short-term investments totaled $13.5 million at June 30.
• Raised full-year revenue guidance to $45 million-$47 million; sees Q3 revenue of $11.5 million-$12 million, up 14%-19% year over year.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myomo Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260805360556) on August 05, 2026, and is solely responsible for the information contained therein.